AGIO:NASDAQ
Agios Pharmaceuticals Inc
$32.78
arrow_downward
-1.92%(-0.64) 1D
Set 29, 11:27:12 AM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa AGIO...
Buksan
$33.21
Mataas
$33.54
Mababa
$32.70
Mkt. cap
1.96B
Avg. na dami
942.38K
Dami
56.80K
Mataas nang 52-wk
$45.99
Mababa nang 52-wk
$22.24
EPS
-$7.01
Beta
0.60
Mga natitirang share
59.70M
Bilang ng mga empleyado
540
Buksan
$33.21
Mataas
$33.54
Mababa
$32.70
Mkt. cap
1.96B
Avg. na dami
942.38K
Dami
56.80K
Mataas nang 52-wk
$45.99
Mababa nang 52-wk
$22.24
EPS
-$7.01
Beta
0.60
Mga natitirang share
59.70M
Bilang ng mga empleyado
540
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Tungkol sa Agios Pharmaceuticals Inc